Učitavanje...

Response to standard therapies and comprehensive genomic analysis for patients with lung adenocarcinoma with EGFR exon 20 insertions

PURPOSE: EGFR exon 20 insertions (ex20ins) are an uncommon genotype in non-small cell lung cancer (NSCLC) for which targeted therapies are under development. We sought to describe treatment outcomes and genomic and immunophenotypic characteristics of these tumors. EXPERIMENTAL DESIGN: We identified...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cancer Res
Glavni autori: Choudhury, Noura J., Schoenfeld, Adam J., Flynn, Jessica, Falcon, Christina, Rizvi, Hira, Rudin, Charles M., Kris, Mark G., Arcila, Maria E., Heller, Glenn, Yu, Helena A., Ladanyi, Marc, Riely, Gregory J.
Format: Artigo
Jezik:Inglês
Izdano: 2021
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8127357/
https://ncbi.nlm.nih.gov/pubmed/33685865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-4650
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!